#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peritoneal mesothelioma malignant Staphylococcal infection Non-Hodgkin's lymphoma refractory Mastocytosis Bulbospinal muscular atrophy congenital Adenomatous polyposis coli Neonatal asphyxia Oesophageal achalasia Haemophilia B with anti factor IX Chronic lymphocytic leukaemia refractory Prodromal Alzheimer's disease Primary immunodeficiency syndrome Infection in an immunocompromised host Small cell lung cancer recurrent Rett syndrome More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Basic Information Angelman’s syndrome Gaucher’s disease type I Angiosarcoma metastatic – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Systemic mastocytosis – Basic Information Factor IX deficiency Waldenstrom’s macroglobulinaemia Sarcoidosis – Life with Disease Behcet’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fezolinetant Bi 764532 Air, Medicinal Ioversol Riociguat Leniolisib Phosphate Romosozumab Ttx-030 Trandolapril Dimeticone Procarbazine Gentamicin Eculizumab Methohexital Sodium Quercus Ilex Allergen Extract Emraclidine Levocabastine Hydrochloride Diacerein Omeprazole Esketamine More therapies…

    Learn about Your Condition

    Eclampsia Oropharyngeal cancer Meniscus operation Spinal cord injury cervical Adrenocortical carcinoma Undifferentiated sarcoma Polyneuropathy Cholangiocarcinoma Paget's disease of the vulva Breast cancer in situ Glioblastoma Pulmonary venous thrombosis Hyperlipidaemia Carotid artery occlusion Tendon rupture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Atopic Dermatitis Treatment with Baricitinib, Tralokinumab, Abrocitinib, Upadacitinib, and Dupilumab for Patients Needing Second-Line Systemic Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Tralokinumab
    • Baricitinib
    • Abrocitinib
    Spain

  • Study on the Effectiveness of L19IL2 and L19TNF Injections with Surgery for Patients with Stage IIIB/C Melanoma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Superficial spreading melanoma stage III
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    Germany Italy Spain Sweden

  • Study on FOLFOX Chemotherapy for Treating Advanced Colon Cancer in Patients Aged 70 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France

  • Study on Pancreas Powder for Digestive Issues in Patients with Unresectable Pancreatic Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pancreas Powder
    France Italy Spain Sweden

  • Study on Improving Treatment for Young Adults with Poor-Prognosis Non-Seminomatous Germ-Cell Tumors Using Paclitaxel and Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lenograstim
    • Bleomycin Sulfate
    • Mesna
    France

  • Study on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Benzylpenicillin Sodium
    • Cefalexin
    • Cefazolin
    France Germany The Netherlands Sweden
Previous Page
1 … 599 600 601 602 603 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!